Lung Cancer Biosimilar Study

Lung Cancer Biosimilar StudyLung Cancer Biosimilar Study

Boehringer Ingelheim has an international clinical research study with a potential new treatment for nonsquamous non-small cell lung cancer.  Back in May during Clinical Trials Awareness Week, we mentioned the importance of taking part in clinical research and shared six interesting facts about clinical trials.  Many of the major advances that have been made in diagnosing and treating various diseases and cancers today would not have happened if it weren’t for those who participated in clinical trials.  

You can also be part of helping to change the face of lung cancer specifically by participating in this study.  To find out if you are eligible, click here.  You can also go to our Clinical Trials Resource Page to find other opportunities or our Clinical Trial Frequently Asked Questions to learn more about what is involved when participating in a clinical trial.

Volunteer To Help Research Advanced Lung Cancer.


Leave a Reply

(0 / 500)

GuideStar Gold Participant